826 abstracts found.



Results filter

Repression of 4F2hc impairs tumorigenicity

Year:

Session type:

Angélica Santiago-Gómez (1), Javier Turnay (1), Emilio Lecona (1), Nieves Olmo (1), Hans Burghardt (2), Manuel Palacín (2), Mª Antonia Lizarbe (1)
Dept. Biochemistry and Molecular Biology I, Faculty of Chemistry, Complutense University of Madrid, Madrid, Spain (1), Institute for Research in Biomedicine (IRB), Barcelona, Spain (2)

Phase II Study of Single Agent Capecitabine in the Treatment of Metastatic Neuroendocrine Tumours

Year:

Session type:

Felicity Murphy (1), Louise Medley (1), Armand Morel (1), David Farrugia (2), Nicholas Reed (3), Joanne Davies (1), Oksana Kirichek (1), Rajesh Thakker (4), Denis Talbot (1)

Department of Medical Oncology, University of Oxford, Oxford, United Kingdom (1), Gloucestershire Hospital NHS Foundation Trust, Cheltenham General Hospital, Cheltenham, United Kingdom (2), Beatson Oncology Centre, Western Infirmary, Glasgow, United Kingdom (3), Oxford Centre for Diabetes, Endocrinology & Metabolism, Oxford, United Kingdom (4)


Burden on primary caregivers of individuals with pancreatic cancer: results from the all-Ireland PanCAM study

Year:

Session type:

Damian O'Driscoll (1), Michael O'Rorke (2), Linda O'Keeffe (1), Kevin Conlon (3), Liam Murray (2), Linda Sharp (1)
National Cancer Registry Ireland, Cork, Ireland (1), Queens University, Belfast, United Kingdom (2), Adelaide and Meath Hospital, Dublin Incorporating the National Children's Hospital, Dublin, Ireland (3)

Investigating the role of lysyl oxidase (LOX) in renal cell carcinoma development

Year:

Session type:

Abdul Karim Fallah (1), Qiuyu Wang (1), John Gaffney (1), Pat Kumar (1), Shant Kumar (1), Mark Slevin (1)
Manchester Metropolitan University, Manchester, United Kingdom (1)

High dose interleukin-2 can produce a very high rate of response in appropriately selected patients with metastatic renal cancer both in treatment naïve and patients pre-treated with sunitinib

Year:

Session type:

Robert Hawkins (1), Alaaeldin Shablak (1), Kanwal Sikand (2), Jonathan Shanks (1), Fiona Thistlethwaite (1), Andrea Spencer-Shaw (2)
University of Manchester and Christie Hospital, Manchester, United Kingdom (1), The Christie Hospital, Manchester, United Kingdom (2)

Targeting microRNA to induce cell death in Medulloblastoma

Year:

Session type:

Yuen Ngan Fan (1), Daniel Meley (1), Dave G Spiller (1), Mike RH White (1), Barry Pizer (2), Violaine See (1)
University of Liverpool, Liverpool, United Kingdom (1), Alder Hey Hospital, Liverpool, United Kingdom (2)

Pim kinases are essential for survival of Myc-induced lymphoma cells in vitro

Year:

Session type:

Linus Plym Forshell (1), Tacha Zi Plym Forshell (1), Jonas Nilsson (1)
Department of Molecular Biology, Umeå, Sweden (1), Department of Molecular Biology, Umeå, Sweden (2), Department of Molecular Biology, Umeå, Sweden (3)

An Application of Zinc Finger Nuclease Technology to Create Knockout Cancer Lines

Year:

Session type:

Suzanne Hibbs (1), Gregory Wemhoff (1), Gary Davis (1)
Sigma Aldrich, Saint Louis, MO, United States (1)

HER-2 expression has no adverse prognostic signficance in caucasian patients with gastro-oesophageal adenocarcinomas: Analysis of Brightfield double In Situ hybridisation (BDISH) for HER-2 gene amplification and immunohistochemistry for HER-2 protein expression

Year:

Session type:

Michelle Cunnell (1), Alex Reecesmith (2), Irshad Soomro (3), Zia Chaudry (3), Ian Ellis (3), Simon Parsons (2), Srinivasan Madhusudan (1)
Academic Unit of Oncology, School of Molecular Medical Sciences, Faculty of Medicine & Health Sciences, University of Nottingham, Nottingham University Hospitals, Nottingham, United Kingdom (1), Department of Surgery, Nottingham University Hospitals, Nottingham, United Kingdom (2), Department of Pathology, Nottingham University Hospitals, Nottingham, United Kingdom (3)

P-cadherin identifies cells with stem-like properties in basal-like breast cancer

Year:

Session type:

Andre F Vieira (1), Sara Ricardo (1), Matthew Ablett (2), Raquel Seruca (3), Fernando Schmitt (3), Robert B Clarke (2), Joana Paredes (1)
Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal (1), Paterson Institute for Cancer Research, Manchester, United Kingdom (2), Medical Faculty of the University of Porto, Porto, Portugal (3)

Page 1 of 831...25...Last »